Purdue Pharma faces more than 1,000 lawsuits claiming it ignited and fuelled the US opioid crisis, reports David Crow. Prosecutors say the company exaggerated the benefits of its painkiller OxyContin, but through their ownership of Rhodes Pharma, Purdue’s owners also have a far bigger market share than was realised.

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on The Big Read when a new story is published

Copyright The Financial Times Limited 2020. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast